What happened
A recent AWS deployment using a GraphRAG architecture has reduced drug research and development cycles by 87 percent, according to a report from AI News. The system integrates previously isolated proprietary databases into a single, queryable knowledge graph.
Initial discovery phases that once took over six months now conclude in three weeks. The architecture uses Amazon Neptune Analytics for the graph database and Amazon Bedrock—running Anthropic’s Claude 4.5 Sonnet—for natural language processing and summarisation.
How the room's reading it
The deployment is being framed as a blueprint for any enterprise struggling with fragmented data. The main challenge, as data science teams point out, is the heavy lift of data normalisation and schema governance required to prevent inaccurate relational mapping. Getting this right is non-trivial and requires careful configuration of tools like Amazon Comprehend Medical and custom Lambda functions.
Still, the consensus among builders is that the results justify the effort. The architecture's modularity is seen as a major plus, allowing teams to swap out language models or tweak the graph structure. The ability to produce verifiable citations and retain knowledge when staff depart are seen as core enterprise benefits.
Sailfish's take
We've seen a lot of RAG demos. Most are just vector search over a pile of PDFs. This is different — it’s a reminder that the 'retrieval' part of RAG is where the real work happens. The 87% improvement wasn't pulled from a better LLM; it came from structuring the data properly in a knowledge graph first.
This is the hard part that most teams skip. For us, the key takeaway isn't the specific AWS tooling, but the proof that sophisticated data architecture is the main driver of value in enterprise AI. If your RAG project isn't delivering, don't chase a new model. Go fix your data structure.